Home › Research › Getting a diagnosis
Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM.. Archives of neurology, 1998-11-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Background Recent studies suggest that vascular disease may contribute to the cause of Alzheimer disease (AD). Since elevated plasma total homocysteine (tHcy) level is a risk factor for vascular disease, it may also be relevant to AD. Objective To examine the association of AD with blood levels of tHcy, and its biological determinants folate and vitamin B12. Design Case-control study of 164 patients, aged 55 years or older, with a clinical diagnosis of dementia of Alzheimer type (DAT), including 76 patients with histologically confirmed AD and 108 control subjects. Setting Referral population to a hospital clinic between July 1988 and April 1996. Main outcome measures Serum tHcy, folate, and vitamin B12 levels in patients and controls at entry; the odds ratio of DAT or confirmed AD with elevated tHcy or low vitamin levels; and the rate of disease progression in relation to tHcy levels at entry. Results Serum tHcy levels were significantly higher and serum folate and vitamin B12 levels were lower in patients with DAT and patients with histologically confirmed AD than in controls. The odds ratio of confirmed AD associated with a tHcy level in the top third (> or = 14 micromol/L) compared with the bottom third ( Conclusions Low blood levels of folate and vitamin B12, and elevated tHcy levels were associated with AD. The stability of tHcy levels over time and lack of relationship with duration of symptoms argue against these findings being a consequence of disease and warrant further studies to assess the clinical relevance of these associations for AD.
What this study adds
Evidence grade: Moderate
This is a case-control study of 164 participants. This 1998 hospital-clinic study compared 164 people with a clinical diagnosis of Alzheimer's (76 of them confirmed by brain tissue) with 108 people without dementia. Patients had "significantly higher" blood homocysteine and lower folate and vitamin B12 levels than controls.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Clarke, R., Smith, A. D., Jobst, K. A., Refsum, H., Sutton, L., & Ueland, P. M. (1998). Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of neurology. https://doi.org/10.1001/archneur.55.11.1449
Vancouver
Clarke R, Smith AD, Jobst KA, Refsum H, Sutton L, Ueland PM. Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease. Archives of neurology. 1998. doi:10.1001/archneur.55.11.1449. PMID: 9823829.
BibTeX
@article{clarke1998-9823829,
author = {Clarke, R. and Smith, A. D. and Jobst, K. A. and Refsum, H. and Sutton, L. and Ueland, P. M.},
title = {{Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease}},
journal = {Archives of neurology},
year = {1998},
doi = {10.1001/archneur.55.11.1449},
pmid = {9823829},
url = {https://doi.org/10.1001/archneur.55.11.1449}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Background Recent studies suggest that vascular disease may contribute to the cause of Alzheimer disease (AD).
- Results Serum tHcy levels were significantly higher and serum folate and vitamin B12 levels were lower in patients with DAT and patients with histologically confirmed AD than in controls.
- The odds ratio of confirmed AD associated with a tHcy level in the top third (> or = 14 micromol/L) compared with the bottom third ( Conclusions Low blood levels of folate and vitamin B12, and elevated tHcy levels were associated with AD.
- The stability of tHcy levels over time and lack of relationship with duration of symptoms argue against these findings being a consequence of disease and warrant further studies to assess the clinical relevance of these associations for AD.
Why it matters
This 1998 hospital-clinic study compared 164 people with a clinical diagnosis of Alzheimer's (76 of them confirmed by brain tissue) with 108 people without dementia. Patients had "significantly higher" blood homocysteine and lower folate and vitamin B12 levels than controls. The authors argued that homocysteine levels being stable over time and unrelated to how long symptoms had lasted made it unlikely the levels were simply a result of the disease. Because blood was measured after diagnosis and no one was given vitamins, the study shows an association only; it does not show that these levels cause Alzheimer's or that taking B vitamins prevents or treats it.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Study designcase-control study
- Participants164
- Evidence strengthModerate
How this study scored 65/100
Published in a peer-reviewed journal, and it is a case-control study. Scored zero for effect reported and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Archives of neurology) |
| Journal's citation record | 3 / 4 | Archives of Neurology: journal h-index 353 (OpenAlex, 2026-10-29) |
| Study design | 6 / 12 | A case-control study |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1998 — older than 20 years, still counted |
| Sample size | 2 / 4 | 164 participants |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,415 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 47.2 citations a year over 30 year(s) since 1998 |
| Impact for its field and year | 5 / 6 | Cited 26.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 4 / 6 | Cited by 36 other studies in this library |
| Still being cited | 2 / 4 | Cited 33 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 4 / 4 | Last-listed author Per Magne Ueland: h-index 116 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Oxford: institution h-index 2,205 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 9823829) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 65 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
36 studies in the alzhub library list this one in their references. Showing the 8 highest-scoring.
Related studies in Getting a diagnosis from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.